Author:
Reed Caitlin,Daar Eric S.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Panel on Clinical Practices for Treatment of HIV Infection:. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://AIDSinfo.nih.gov. Accessed August 9, 2006. One of the premiere up-to-date resources on current management of HIV-1-infected individuals.
2. Kaufmann D, Pantaleo G, Sudre P, et al.: CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Swiss HIV Cohort Study. Lancet 1998, 351:723–724.
3. Struble K, Murray J, Cheng B, et al.: Antiretroviral therapies for treatment-experienced patients: current status and research challenges. AIDS 2005, 19:747–756.
4. Bethell R: Antiviral activity of SPD754 against clinical isolates of HIV-1 resistant to other NRTIs. Presented at the 12th International HIV Drug Resistance Workshop. Cabo San Lucas, Mexico; June 10–14, 2003.
5. Gu Z, Allard B, de Muys JM, et al.: In vitro antiretroviral activity and in vitro toxicity profile of SPD754, a new deoxycytidine nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus infection. Antimicrob Agents Chemother 2006, 50:625–631.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献